Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men

被引:140
作者
Tabardel, Y
Duchateau, J
Schmartz, D
Marecaux, G
Shahla, M
Barvais, L
Leclerc, JL
Vincent, JL
机构
[1] ERASME UNIV HOSP,DEPT INTENS CARE,B-1070 BRUSSELS,BELGIUM
[2] ERASME UNIV HOSP,DEPT CARDIAC SURG,B-1070 BRUSSELS,BELGIUM
[3] FREE UNIV BRUSSELS,BRUGMANN HOSP,DEPT IMMUNOALLERGOL,B-1050 BRUSSELS,BELGIUM
关键词
D O I
10.1016/S0039-6060(96)80217-0
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Interleukin (IL)-10 is a potent antiinflammatory cytokine inhibiting the release of tumor necrosis factor-alpha (TNF-alpha) and IL-8 by activated macrophages and polymorphonuclear leukocytes. Cardiopulmonary bypass (CPB) represents a unique situation where an inflammatory reaction is predictably induced. The present study examined the influence of CPB on the release of TNF-alpha, IL-1 beta, IL-8, and IL-10 and also defined the effects of pretreatment with corticosteroids on the release of these cytokines. Methods. The study included 22 patients undergoing coronary artery bypass graft operations, including eight control patients and seven patients who received dexamethasone, and seven patients who received methylprednisolone 4 hours before the operation. Cytokines were measured with the enzyme-linked immunosorbent assay technique before treatment, before anesthesia induction, immediately before heparin administration, before aorta declamping, 10 minutes and 90 minutes after aorta declamping, and 4 hours after the end of CPB. Results. In the control patients the TNF-alpha levels and especially the IL-8 levels increased during CPB and reached their maximal levels 4 hours after CPB. IL-10 levels rose moderately and transiently, reaching peak values 90 minutes after aorta declamping. Notably, administration of corticosteroids prevented 1L-8 release but increased IL-10 levels, which were tenfold higher than in the control group 90 minutes after aorta declamping (dexamethasone, 271 +/- 128 pg/ml; methylprednisolone, 312 +/- 213 pg/ml; control, 17 +/- 12 pg/ml, p < 0.05). IL-1 beta was not detected in any group of patients. Conclusions, The present data indicate that IL-10 is released together with proinflammatory cytokines during and after CPB and that pretreatment with corticosteroids markedly enhances this release. The release of IL-10 may play an important role in the antiinflammatory effects of corticosteroids.
引用
收藏
页码:76 / 80
页数:5
相关论文
共 20 条
[1]   INTERLEUKIN-10 PROTECTS MICE AGAINST STAPHYLOCOCCAL-ENTEROTOXIN B-INDUCED LETHAL SHOCK [J].
BEAN, AGD ;
FREIBERG, RA ;
ANDRADE, S ;
MENON, S ;
ZLOTNIK, A .
INFECTION AND IMMUNITY, 1993, 61 (11) :4937-4939
[2]   INTERLEUKIN-10 (IL-10) INHIBITS THE RELEASE OF PROINFLAMMATORY CYTOKINES FROM HUMAN POLYMORPHONUCLEAR LEUKOCYTES - EVIDENCE FOR AN AUTOCRINE ROLE OF TUMOR-NECROSIS-FACTOR AND IL-1-BETA IN MEDIATING THE PRODUCTION OF IL-8 TRIGGERED BY LIPOPOLYSACCHARIDE [J].
CASSATELLA, MA ;
MEDA, L ;
BONORA, S ;
CESKA, M ;
CONSTANTIN, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2207-2211
[3]   INTERLEUKIN-10 (IL-10) UP-REGULATES IL-1 RECEPTOR ANTAGONIST PRODUCTION FROM LIPOPOLYSACCHARIDE-STIMULATED HUMAN POLYMORPHONUCLEAR LEUKOCYTES BY DELAYING MESSENGER-RNA DEGRADATION [J].
CASSATELLA, MA ;
MEDA, L ;
GASPERINI, S ;
CALZETTI, F ;
BONORA, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (05) :1695-1699
[4]   COMPLEMENT ACTIVATION DURING CARDIOPULMONARY BYPASS - EVIDENCE FOR GENERATION OF C3A AND C5A ANAPHYLATOXINS [J].
CHENOWETH, DE ;
COOPER, SW ;
HUGLI, TE ;
STEWART, RW ;
BLACKSTONE, EH ;
KIRKLIN, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (09) :497-503
[5]  
FAYMONVILLE ME, 1991, J THORAC CARDIOV SUR, V102, P309
[6]   INTERLEUKIN-8 RELEASE AND NEUTROPHIL DEGRANULATION AFTER PEDIATRIC CARDIOPULMONARY BYPASS [J].
FINN, A ;
NAIK, S ;
KLEIN, N ;
LEVINSKY, RJ ;
STROBEL, S ;
ELLIOTT, M .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1993, 105 (02) :234-241
[7]  
FRERING B, 1994, J THORAC CARDIOV SUR, V108, P636
[8]   PROTECTIVE EFFECT OF CHLORPROMAZINE ON ENDOTOXIN TOXICITY AND TNF PRODUCTION IN GLUCOCORTICOID-SENSITIVE AND GLUCOCORTICOID-RESISTANT MODELS OF ENDOTOXIC-SHOCK [J].
GADINA, M ;
BERTINI, R ;
MENGOZZI, M ;
ZANDALASINI, M ;
MANTOVANI, A ;
GHEZZI, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (06) :1305-1310
[9]  
HAEFFNERCAVAILLON N, 1989, J THORAC CARDIOV SUR, V98, P1100
[10]  
HAMMERSCHMIDT DE, 1981, J THORAC CARDIOV SUR, V81, P370